Form D Explorer
Inflammasome Therapeutics, Inc. · CIK 1989925

Report a data issueCitable research briefCompare issuerPrivate research collection

Inflammasome Therapeutics, Inc.

CIK 1989925 · Corporation · Inc. DELAWARE · NEWTON, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Mar 17, 2025
through May 4, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 17, 2025 · DMay 4, 2026 · DLater minus earlier
Reported offering amount$10,000,000$13,155,645$3,155,645
Reported amount sold$2,450,172$13,155,645$10,705,473
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0002060536-25-000002 · Later SEC source: 0001989925-26-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · May 4, 2026

Reported offering amount
$13,155,645
Reported exemptions
Rule 506(b)
Reported amount sold
$13,155,645

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)